Philips Healthcare's Blockchain Lead is Leaving Next Month

The founder and head of Philips Blockchain Lab, Arno Laeven, is leaving the healthcare giant effective 1st August.

AccessTimeIconJul 29, 2016 at 3:04 p.m. UTC
Updated Sep 11, 2021 at 12:23 p.m. UTC

The founder and head of Philips Blockchain Lab is leaving the healthcare giant effective 1st August for new opportunities in the blockchain sector.

Arno Laeven, who led a 12-person internal team which investigated how blockchain tech could be applied to healthcare, said he will be departing for "new adventures" in the industry, but declined additional comment. Laeven was formerly global IT innovation lead, before founding the Philips Blockchain Lab in January.

Laeven will be succeeded by Patrick van Beers, senior director of digital platform solutions at Philips Research.

The announcement comes as blockchain leads at major banks are continuing to depart for entrepreneurial opportunities. Barclays blockchain lead Simon Taylor, for example, revealed he would be leaving the UK bank for a new venture fund, 11:FS, in June.

Soon after, blockchain leads at JPMorgan, State Street and BNP Paribas were found to be exiting their positions for new roles in the startup space.

Philips has been early among major healthcare firms in investigating blockchain’s potential, first announcing it would explore applications in October, before formally launching an Amsterdam-based R&D lab for the technology in March.

Image via YouTube

Read more about


Please note that our privacy policy, terms of use, cookies, and do not sell my personal information has been updated.

The leader in news and information on cryptocurrency, digital assets and the future of money, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups. As part of their compensation, certain CoinDesk employees, including editorial employees, may receive exposure to DCG equity in the form of stock appreciation rights, which vest over a multi-year period. CoinDesk journalists are not allowed to purchase stock outright in DCG.